Status:
COMPLETED
Renal Arterial Resistive Index Versus Novel Biomarkers for Early Prediction of Sepsis Associated-acute Kidney Injury
Lead Sponsor:
Islam Elsayed Mohamed Ahmed
Conditions:
Sepsis
Septic Shock
Eligibility:
All Genders
18+ years
Brief Summary
Populations at high risk of Sepsis-Associated Acute Kidney Injury (SA-AKI) have been identified. Sources of sepsis, in particular, bloodstream infection, abdominal and genitourinary sepsis, and infect...
Detailed Description
All included patients in this study will be assessed for the following: 1. Data Collection * Complete history taking (age, sex, illness, medications, etc.). * Complete physical examination (Gl...
Eligibility Criteria
Inclusion
- Adult patients (aged above 18 years) recently admitted with sepsis
Exclusion
- Pregnant Females
- Patients with renal transplant.
- Patients with End Stage Renal Disease (ESRD).
- Patients with Chronic Kidney Disease (CKD) known with history, laboratory or ultrasonographic evaluation with chronic nephropathic changes.
- Patients with renal artery stenosis.
- Patients with obstructive uropathy.
Key Trial Info
Start Date :
May 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2021
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT03799159
Start Date
May 15 2019
End Date
February 28 2021
Last Update
March 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alexandria Main University Hospital
Alexandria, Egypt, 21563